97 related articles for article (PubMed ID: 9825844)
1. IL-4, IL-10 and IL-13 in acute myelogenous leukemia.
Bruserud O
Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844
[TBL] [Abstract][Full Text] [Related]
2. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
3. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities.
Bruserud Ø; Hovland R; Wergeland L; Huang TS; Gjertsen BT
Haematologica; 2003 Apr; 88(4):416-28. PubMed ID: 12681969
[TBL] [Abstract][Full Text] [Related]
4. Effects of normal platelets on proliferation and constitutive cytokine secretion by human acute myelogenous leukaemia blasts.
Bruserud Ø; Foss B; Hervig T
Platelets; 1997; 8(6):397-404. PubMed ID: 16793674
[TBL] [Abstract][Full Text] [Related]
5. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
Bruserud O; Tore Gjertsen B; Brustugun OT; Bassøe CF; Nesthus I; Espen Akselsen P; Bühring HJ; Pawelec G
Leukemia; 1995 Nov; 9(11):1910-20. PubMed ID: 7475283
[TBL] [Abstract][Full Text] [Related]
6. Divergent effects of IL-10 and IL-4 on the proliferation and growth factor secretion by acute myeloblastic leukemic cells.
Tuyt LM; Dokter WH; Esselink MT; Vellenga E
Eur Cytokine Netw; 1995; 6(4):231-5. PubMed ID: 8789288
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor.
Bruserud Ø; Foss B; Ulvestad E; Hervig T
Platelets; 1998; 9(6):352-8. PubMed ID: 16793718
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
Bruserud O
Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
[TBL] [Abstract][Full Text] [Related]
9. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
[TBL] [Abstract][Full Text] [Related]
10. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
Bruserud O; Ulvestad E
J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
[TBL] [Abstract][Full Text] [Related]
11. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
Foss B; Mentzoni L; Bruserud O
J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 4 (IL4), IL10 and IL13 Inhibit in vitro Cytokine Secretion by Acute Myelogenous Leukemia Blasts in the Presence of Exogenous Hematopoietic Growth Factors.
Bruserud Ø
Hematology; 1998; 3(6):443-50. PubMed ID: 27420331
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud O
Eur J Haematol; 2001 Jun; 66(6):365-76. PubMed ID: 11488935
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
Foss B; Ulvestad E; Bruserud Ø
Eur J Haematol; 2001 Oct; 67(4):267-78. PubMed ID: 11860452
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
17. Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients.
Nowak R; Oelschlägel U; Gurth H; Range U; Albrecht S; Krebs U; Hietschold V; Ehninger G
Cytokine; 1999 Jun; 11(6):435-42. PubMed ID: 10346983
[TBL] [Abstract][Full Text] [Related]
18. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
